HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 211 filers reported holding HORIZON PHARMA PLC in Q1 2017. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $4,394,000 | +35.7% | 166,217 | +0.3% | 0.05% | +14.3% |
| Q4 2018 | $3,239,000 | -0.2% | 165,734 | 0.0% | 0.04% | +35.5% |
| Q3 2018 | $3,245,000 | +18.2% | 165,734 | 0.0% | 0.03% | +14.8% |
| Q2 2018 | $2,745,000 | +16.7% | 165,734 | 0.0% | 0.03% | +12.5% |
| Q1 2018 | $2,353,000 | -8.8% | 165,734 | -6.2% | 0.02% | 0.0% |
| Q4 2017 | $2,581,000 | +15.2% | 176,748 | 0.0% | 0.02% | +33.3% |
| Q3 2017 | $2,241,000 | +4.7% | 176,748 | -2.0% | 0.02% | 0.0% |
| Q2 2017 | $2,140,000 | -22.3% | 180,275 | -3.3% | 0.02% | -25.0% |
| Q1 2017 | $2,754,000 | -7.2% | 186,354 | +1.6% | 0.02% | 0.0% |
| Q4 2016 | $2,967,000 | -17.7% | 183,383 | -7.7% | 0.02% | -14.3% |
| Q3 2016 | $3,604,000 | +159.1% | 198,762 | +135.4% | 0.03% | +133.3% |
| Q2 2016 | $1,391,000 | +139000.0% | 84,446 | +703616.7% | 0.01% | – |
| Q4 2015 | $1,000 | – | 12 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JABODON PT CO | 187,808 | $4,519,000 | 3.52% |
| KNOTT DAVID M | 50,046 | $1,204,000 | 0.51% |
| CASTLEARK MANAGEMENT LLC | 362,980 | $8,733,000 | 0.34% |
| EAGLE ASSET MANAGEMENT INC | 2,692,100 | $64,771,000 | 0.33% |
| USA FINANCIAL FORMULAS | 15,202 | $402,000 | 0.20% |
| Qtron Investments LLC | 12,274 | $295,000 | 0.18% |
| C WorldWide Group Holding A/S | 491,544 | $11,827,000 | 0.15% |
| Gotham Asset Management, LLC | 207,158 | $4,984,000 | 0.08% |
| Russell Investments Group, Ltd. | 608,977 | $14,652,000 | 0.03% |
| FNY Investment Advisers, LLC | 3,350 | $80,000 | 0.02% |